Ginkgo Bioworks
- Market cap
- 772.39M
- P/E (TTM)i
- -2.29
- P/Bi
- 1.84
- EPSi
- -5.64
- Div yieldi
- 0.00%
- 52W posi
- 47%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 7.0 percentage points.
Institutional ownership
- Held by institutions
- 59.06% -6.99pp
- Institutions
- 216 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 18 buys · 32 sells
| Name | Role | Stake |
|---|---|---|
| Reshma Shetty | Founder, President, COO & Director | 3.69% |
| Austin Che | Founder, Head of Strategy & Treasurer | 3.54% |
| Bartholomew Canton | Founder, CTO & Secretary | 3.54% |
| Jason Kelly | Chief Executive Officer | 3.50% |
| Harry Sloan | Independent Director | 0.40% |
| Shyam Sankar | Independent Chairperson | 0.11% |
| Steven Coen | Chief Accounting Officer | 0.08% |
| Sriram Kosuri | Director | 0.04% |
| Christian O. Henry | Independent Director | 0.03% |
| Ross Fubini | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | Steven Coen | Chief Accounting Officer | Intent to Sell (Form 144) | -2,403 | $15.00 |
| 2026-09-16 | Austin Che | Founder, Head of Strategy & Treasurer | Intent to Sell (Form 144) | -2,200 | $7.29 |
| 2026-09-14 | Christian O. Henry | Independent Director | Open Market Disposition | -5,000 | $7.08 |
| 2026-08-23 | Steven Coen | Chief Accounting Officer | Derivative Exercise and Sale | -330 | $6.98 |
| 2026-08-23 | Steven Coen | Chief Accounting Officer | Intent to Sell (Form 144) | -330 | $6.98 |
| 2026-08-20 | Steven Coen | Chief Accounting Officer | Derivative Exercise and Retained | +413 | -- |
| 2026-08-16 | Austin Che | Founder, Head of Strategy & Treasurer | Intent to Sell (Form 144) | -2,200 | $6.66 |
| 2026-07-27 | Jason Kelly | Chief Executive Officer | Other Derivative Acquisition | +383,725 | -- |
| 2026-07-27 | Reshma Shetty | Founder, President, COO & Director | Other Derivative Acquisition | +319,332 | -- |
| 2026-07-27 | Bartholomew Canton | Founder, CTO & Secretary | Other Derivative Acquisition | +319,332 | -- |
| 2026-07-16 | Steven Coen | Chief Accounting Officer | Derivative Exercise and Sale | -752 | $7.90 |
| 2026-07-16 | Steven Coen | Chief Accounting Officer | Intent to Sell (Form 144) | -752 | $7.90 |
| 2026-07-15 | Steven Coen | Chief Accounting Officer | Derivative Exercise and Retained | +734 | -- |
| 2026-06-10 | Harry Sloan | Independent Director | Other Derivative Acquisition | +25,000 | -- |
| 2026-06-10 | Christian O. Henry | Independent Director | Other Derivative Acquisition | +25,000 | -- |
| 2026-06-10 | Ross Fubini | Independent Director | Other Derivative Acquisition | +25,000 | -- |
| 2026-06-10 | Sriram Kosuri | Director | Other Derivative Acquisition | +25,000 | -- |
| 2026-06-09 | Austin Che | Founder, Head of Strategy & Treasurer | Intent to Sell (Form 144) | -2,200 | $8.06 |
| 2026-05-21 | Steven Coen | Chief Accounting Officer | Derivative Exercise and Sale | -307 | $8.33 |
| 2026-05-21 | Steven Coen | Chief Accounting Officer | Intent to Sell (Form 144) | -307 | $8.33 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:20:28 · For reference only, not investment advice and not tailored to your situation.